Age-associated augmentation of the synthetic ligand-mediated function of mouse NK1.1 Ag+ T cells: Their cytokine production and hepatotoxicity in vivo and in vitro

Journal of Immunology

Volumn 169, Issue 11, 2002, Pages 6127-6132

  Inui, Takuo ^a   Nakagawa, Ryusuke ^b   Ohkura, Shuri ^a,c   Habu, Yoshiko ^a   Koike, Yuji ^a   Motoki, Kazuhiro ^b   Kuranaga, Noritsugu ^a   Fukasawa, Masashi ^a   Shinomiya, Nariyoshi ^a   Seki, Shuhji ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b KIRIN BREWERY CO LTD   (Japan)

^c OCHANOMIZU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 O (ALPHA GALACTOPYRANOSYL) 2 HEXACOSANOYLAMINO 1,3,4 OCTADECANETRIOL; ALANINE AMINOTRANSFERASE; ALPHA GALACTOSYLCERAMIDE; FAS ANTIGEN; FAS LIGAND; GALACTOSYLCERAMIDE; GAMMA INTERFERON; INTERLEUKIN 4; UNCLASSIFIED DRUG; ANTIGEN; CD161 ANTIGEN; CYTOKINE; FASL PROTEIN, MOUSE; LECTIN; LIGAND; MEMBRANE ANTIGEN; MEMBRANE PROTEIN; PROTEIN;

AGE DISTRIBUTION; ANIMAL CELL; ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; EFFECTOR CELL; IN VITRO STUDY; IN VIVO STUDY; INTERFERON PRODUCTION; LIGAND BINDING; LIVER CELL CULTURE; LIVER TOXICITY; MONONUCLEAR CELL; MORTALITY; MOUSE; NATURAL KILLER CELL; NK1.1 AG T CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; STIMULUS RESPONSE; T LYMPHOCYTE ACTIVATION; AGING; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; BLOOD; C57BL MOUSE; CELL DIVISION; CYTOLOGY; IMMUNOLOGY; INJURY; LIVER; LIVER CELL; METABOLISM; T LYMPHOCYTE SUBPOPULATION;

AGING; ALANINE TRANSAMINASE; ANIMALS; ANTIGENS; ANTIGENS, CD95; ANTIGENS, SURFACE; CELL DIVISION; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; FAS LIGAND PROTEIN; GALACTOSYLCERAMIDES; HEPATOCYTES; INTERFERON TYPE II; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LIGANDS; LIVER; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PROTEINS; T-LYMPHOCYTE SUBSETS;

EID: 0036885013     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.11.6127     Document Type: Article

References (39)

1. + αβ T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis. J. Immunol. 156:3366.
2. + αβ T cells with intermediate TCR induced in the liver of mice by IL-12. J. Immunol. 154:4333.
3. Tsukahara, A., S. Seki, T. Iiai, T. Moroda, H. Watanabe, S. Suzuki, T. Tada, H. Hiraide, K. Hatakeyama, and T. Abo. 1997. Mouse liver T cells: their change with aging and in comparison with peripheral T cells. Hepatology 26:301.
4. + T cells in T helper 1 immune responses. Immunol. Rev. 174:35.
5. Makino, Y., H. Koseki, Y. Adachi, T. Akasaka, K. Tsuchida, and M. Taniguchi. 1994. Extrathymic differentiation of a T cell bearing invariant Vα14 Jα281 TCR. Int. Rev. Immunol. 11:31.
6. - T cells in mice and humans. J. Exp. Med. 180:1097.
7. + T cells by CD1-expressing cortical thymocytes. J. Exp. Med. 182:2091.
8. + T cell subsets: a subset (Thy0) that secretes diverse cytokines and overexpresses the Vβ8 T cell receptor gene family. J. Exp. Med. 176:269.
9. - thymocytes with specific lymphokine secretion. Eur. J. Immunol. 23:307.
10. 2-microglobulin and NK1.1 expression. Int. Immunol. 7:1729.
11. + T cells and their IFN-γ production in the generalized Shwartzman reaction. J. Immunol. 160:3522.
12. + NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system. J. Immunol. 163:93.
13. + αβT cells in the lungs of euthymic and athymic mice. Immunology 88:82.
14. + T cells on experimental haematogenous tumour metastases in the liver and lungs of mice. Immunology 92:561.
15. + T cells by bacterial superantigen-primed Kupffer cells. Hepatology 30:430.
16. Morita, M., K. Motoki, K. Akimoto, T. Natori, T. Sakai, E. Sawa, K. Yamaji, Y. Koezuka, E. Kobayashi, and H. Fukushima. 1995. Structure-activity relationship of α-galactosylceramides against B 16-bearing mice. J. Med. Chem. 38:2176.
17. Kawano, T., J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Ueno, R. Nakagawa, H. Sato, E. Kondo, et al. 1997. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 278:1626.
18. Kawano, T., J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, H. Sato, E. Kondo, M. Harada, H. Koseki, T. Nakayama, et al. 1998. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα14 NKT cells. Proc. Natl. Acad. Sci. USA 95:5690,
19. Osman, Y., T. Kawamura, T. Naito, K. Takeda, L. Van Kaer, K. Okumura, and T. Abo. 2000. Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide. Eur. J. Immunol. 30:1919.
20. Nakagawa, R., I. Nagafune, Y. Tazunoki, H. Ehara, H. Tomura, R. lijima, K. Motoki, M. Kamishohara, and S. Seki. 2001. Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by α-galactosylceramide in mice. J. Immunol. 166:6578.
21. Yamaguchi, Y., K. Motoki, H. Ueno, K. Maeda, E. Kobayashi, H. Inoue, H. Fukushima, and Y. Koezuka. 1996. Enhancing effects of (2S,3S,4R)-1-O-(α-D-galactopyranosyl)-2- (N-hexacosanoylamino)-1,3,4-octadecanetriol (KRN7000) on antigen-presenting function of antigen-presenting cells and antimetastatic activity of KRN7000-pretreated antigen-presenting cells. Oncol. Res. 8:399.
22. Motoki, K., K. Maeda, H. Ueno, E. Kobayashi, T. Uchida, H. Fukushima, and Y. Koezuka. 1996. Antitumor activities of combined treatment with a novel immunomodulator, (2S,3S,4R)-1-O-(α-D-galactopyranosyl)-2-(N-hexacosanoylamino)- 1,3,4-octadecanetriol (KRN7000), and radiotherapy in tumor-bearing mice. Oncol. Res. 8:155.
23. Inui, T., N. Shinomiya, M. Fukasawa, M. Kobayashi, N. Kuranaga, S. Ohkura, and S. Seki. 2002. Growth-related signaling regulates activation of telomerase in regenerating hepatocytes. Exp. Cell Res. 273:147.
24. + T cells. J. Immunol. 153:637.
25. + T cells for concanavalin A-induced hepatic injury in mice. J. Immunol. 159:1537.
26. Takeda, K., Y. Hayakawa, L. Van Kaer, H. Matsuda, H. Yagita, and K. Okumura. 2000. Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc. Natl. Acad. Sci. USA 97:5498.
27. Kaneko, Y., M. Harada, T. Kawano, M. Yamashita, Y. Shibata, F. Gejyo, T. Nakayama, and M. Taniguchi. 2000. Augmentation of Vα14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J. Exp. Med. 191:105.
28. Katschinski, T., C. Galanos, A. Coumbos, and M. A. Freudenberg. 1992. γ-Interferon mediates Propionibacterium acnes-induced hypersensitivity to lipopolysaccharide in mice. Infect. Immun. 60:1994.
29. Ferluga, J., and A. C. Allison. 1978. Role of mononuclear infiltrating cells in pathogenesis of hepatitis. Lancet 2:610.
30. Tsuji, H., A. Harada, N. Mukaida, Y. Nakanuma, H. Bluethmann, S. Kaneko, K. Yamakawa, S. I. Nakamura, K. I. Kobayashi, and K. Matsushima. 1997. Tumor necrosis factor receptor p55 is essential for intrahepatic granuloma formation and hepatocellular apoptosis in a murine model of bacterium-induced fulminant hepatitis. Infect. Immun. 65:1892.
31. Tsutsui, H., K. Matsui, N. Kawada, Y. Hyodo, N. Hayashi, H. Okamura, K. Higashino, and K. Nakanishi. 1997. IL-18 accounts for both TNF-α and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice. J. Immunol. 159:3961.
32. Tsuji, H., N. Mukaida, A. Harada, S. Kaneko, E. Matsushita, Y. Nakanuma, H. Tsutsui, H. Okamura, K. Nakanishi, Y. Tagawa, et al. 1999. Alleviation of lipopolysaccharide-induced acute liver injury in Propionibacterium acnes-primed IFN-γ-deficient mice by a concomitant reduction of TNF-α 1L-12, and IL-18 production. J. Immunol. 162:1049.
33. Gilles, P. N., D. L. Guerrette, R. J. Ulevitch, R. D. Schreiber, and F. V. Chisari. 1992. HbsAg retention sensitizes the hepatocyte to injury by physiological concentrations of interferon-γ. Hepatology 16:655.
34. Crispe, I. N., T. Dao, K. Klugewitz, W. Z. Mehal, and D. P. Metz. 2000. The liver as a site of T-cell apoptosis: graveyard, or killing field? Immunol. Rev. 174:47.
35. + NKT cells associated with disease development in autoimmune-prone mice. J. Immunol. 156:4035.
36. Sharif, S., G. A. Arreaza, P. Zucker, Q. S. Mi, J. Sondhi, O. V. Naidenko, M. Kronenberg, Y. Koezuka, T. L. Delovitch, J. M. Gombert, et al. 2001. Activation of natural killer T cells by a-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes. Nat. Med. 7:1057.
37. Hong, S., M. T. Wilson, I. Serizawa, L. Wu, N. Singh, O. V. Naidenko, T. Miura, T. Haba, D. C. Scherer, J. Wei, et al. 2001. The natural killer T-cell ligand a-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 7:1052.
38. + T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma. Hepatology 32:962.
39. Ami, K., T. Ohkawa, Y. Koike, K. Sato, Y. Habu, T. Iwai, S. Seki, and H. Hiraide. 2002. Activation of human T cells with NK cell markers by staphylococcal enterotoxin A via IL-12 but not via IL-18. Clin. Exp. Immunol. 128:453.